EP 1076652 A1 20010221 - N-(3-ETHYNYLPHENYLAMINO)-6,7-BIS(2-METHOXYETHOXY)-4-QUINAZOLINAMINE MESYLATE ANHYDRATE AND MONOHYDRATE
Title (en)
N-(3-ETHYNYLPHENYLAMINO)-6,7-BIS(2-METHOXYETHOXY)-4-QUINAZOLINAMINE MESYLATE ANHYDRATE AND MONOHYDRATE
Title (de)
N-(3-ETHINYLPHENYLAMINO)-6,7-BIS(2-METHOXYETHOXY)-4-CHINAZOLINAMIN-MESYLAT-ANHYDRAT UND -MONOHYDRAT
Title (fr)
ANHYDRATE ET MONOHYDRATE DE N-(3-ETHYNYLPHENYLAMINO)-6,7-BIS(2-METHOXYETHOXY)-4-QUINAZOLINAMINE MESYLATE
Publication
Application
Priority
- IB 9900612 W 19990408
- US 8344198 P 19980429
Abstract (en)
[origin: WO9955683A1] The present invention relates to the anhydrous and hydrate forms of N- (3-ethynylphenyl)-6,7-bis (2-methoxyethoxy)4-quinazolinamine mesylate. The invention also relates to pharmaceutical compositions containing N- (3-ethynylphenyl)-6,7- bis(2-methoxyethoxy) -4-quinazolinamine mesylate and to methods of treating hyperproliferative disorders, such as cancer, by administering N- (3-ethynylphenyl)-6,7- bis(2-methoxyethoxy)-4- quinazolinamine mesylate.
IPC 1-7
IPC 8 full level
A61K 31/505 (2006.01); A61K 31/517 (2006.01); A61P 35/00 (2006.01); C07D 239/94 (2006.01)
CPC (source: EP KR)
A61K 31/517 (2013.01 - KR); A61P 17/06 (2017.12 - EP); A61P 19/10 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 35/04 (2017.12 - EP); C07D 239/94 (2013.01 - EP KR)
Citation (search report)
See references of WO 9955683A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9955683 A1 19991104; AP 1252 A 20040225; AP 9901523 A0 19990630; AR 018201 A1 20011031; AT E295839 T1 20050615; AU 2850999 A 19991116; AU 759691 B2 20030417; AU 759691 C 20040429; BR 9910025 A 20001226; CA 2330447 A1 19991104; CA 2330447 C 20090630; CN 101219999 A 20080716; CN 1298396 A 20010606; CO 5060467 A1 20010730; CZ 20003974 A3 20010516; CZ 298230 B6 20070801; DE 69925366 D1 20050623; DE 69925366 T2 20060309; DZ 2777 A1 20031201; EA 002836 B1 20021031; EA 200001112 A1 20010423; EG 24000 A 20080319; EP 1076652 A1 20010221; EP 1076652 B1 20050518; ES 2238825 T3 20050901; GT 199900063 A 20001020; HK 1037180 A1 20020201; HN 1999000057 A 19990929; HU 227569 B1 20110829; HU P0101818 A1 20020328; HU P0101818 A3 20020528; ID 27198 A 20010308; IL 139172 A0 20011125; JP 2002513009 A 20020508; JP 4652569 B2 20110316; KR 100668412 B1 20070112; KR 20010078710 A 20010821; MA 26624 A1 20041220; ME P42008 A 20110210; MX PA00010610 A 20020702; MY 136033 A 20080731; NO 20005453 D0 20001027; NO 20005453 L 20001220; NO 317301 B1 20041004; NZ 508154 A 20030725; OA 11769 A 20050725; PA 8471001 A1 20000929; PE 20000441 A1 20000523; PL 196940 B1 20080229; PL 343766 A1 20010910; RS 50081 B 20090122; SA 99200216 B1 20060604; TN SN99079 A1 20051110; TR 200003166 T2 20010221; TW I248437 B 20060201; UA 60363 C2 20031015; UY 26099 A1 20011228; YU 66100 A 20030707; ZA 992972 B 20001030
DOCDB simple family (application)
IB 9900612 W 19990408; AP 9901523 A 19990429; AR P990101942 A 19990427; AT 99909165 T 19990408; AU 2850999 A 19990408; BR 9910025 A 19990408; CA 2330447 A 19990408; CN 200810005110 A 19990408; CN 99805497 A 19990408; CO 99026003 A 19990429; CZ 20003974 A 19990408; DE 69925366 T 19990408; DZ 990077 A 19990428; EA 200001112 A 19990408; EG 48299 A 19990429; EP 99909165 A 19990408; ES 99909165 T 19990408; GT 199900063 A 19990429; HK 01105821 A 20010817; HN 1999000057 A 19990426; HU P0101818 A 19990408; ID 20002186 A 19990408; IL 13917299 A 19990408; JP 2000545843 A 19990408; KR 20007011998 A 20001027; MA 25557 A 19990428; ME P42008 A 19990408; MX PA00010610 A 19990408; MY PI9901636 A 19990427; NO 20005453 A 20001027; NZ 50815499 A 19990408; OA 1200000300 A 19990408; PA 8471001 A 19990427; PE 00035699 A 19990429; PL 34376699 A 19990408; SA 99200216 A 19990602; TN SN99079 A 19990428; TR 200003166 T 19990408; TW 88106555 A 19990423; UA 00116681 A 19990408; UY 26099 A 20000405; YU 66100 A 19990408; ZA 992972 A 19990428